Distribution of biomarkers of human exposure to persistent organic pollutants from the group of organohalogen compounds as a result of the impact of the environment

Abstract

Organohalogen compounds constitute one of the important groups of persistent organic pollutants (POPs). Among them, due to their long-term health effects, one should pay attention on polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and perfluoroalkylated substances (PFASs). In case of that anthropogenic group of environmental pollution, the scientific world faces a problem of not only checking their toxic influences on the human organism at different age, from the natal period till late elderly years, but also monitoring the levels of such a numerous group of compounds in various environments, including human tissues and body fluids. This gave birth to a concept of checking the levels of selected biomarkers of exposure in the human organism, calculating body burden and assessing the hazard exposure to human beings. This article is an attempt to answer the question whether testing only biomarkers for different groups of pollutants is enough to determine the threat to different human populations. CB-153 levels represent a significant share in the sum of the six indicator NDL-PCBs (42.96%). In contrary to PCBs, in the case of PBDEs, not only BDE-47 is a biomarker of exposure to the entire PBDEs group, the congener BDE-153 cannot be omitted. Among the compounds belonging to PFASs, only four are detected in the biological material. The PFOS is the dominant representative of this group in the blood samples. It constitutes approximately 75% of the total PFASs.